Neogen (NASDAQ:NEOG) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.11 by 63.64 percent. This is a 20 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $140.09 million which beat the analyst consensus estimate of $138.37 million by 1.24 percent. This is a 9.94 percent increase over sales of $127.42 million the same period last year.
Regeneron Pharmaceuticals, Hess And 1 Of World’s Biggest Bank: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she is sticking with Regeneron Pharmaceuticals, Inc.
